ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia. (Q52882383)

9 May 2018

title

ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia. (English)

1 reference

9 May 2018

14

J Zuna

1 reference

9 May 2018

author name string

M Zaliova

1

1 reference

9 May 2018

O Zimmermannova

2

1 reference

9 May 2018

P Dörge

3

1 reference

9 May 2018

C Eckert

4

1 reference

9 May 2018

A Möricke

5

1 reference

9 May 2018

M Zimmermann

6

1 reference

9 May 2018

J Stuchly

7

1 reference

9 May 2018

A Teigler-Schlegel

8

1 reference

9 May 2018

B Meissner

9

1 reference

9 May 2018

R Koehler

10

1 reference

9 May 2018

C R Bartram

11

1 reference

9 May 2018

L Karawajew

12

1 reference

9 May 2018

P Rhein

13

1 reference

9 May 2018

M Schrappe

15

1 reference

9 May 2018

G Cario

16

1 reference

9 May 2018

M Stanulla

17

1 reference

9 May 2018

publication date

27 September 2013

1 reference

9 May 2018

published in

Leukemia

1 reference

9 May 2018

volume

28

1 reference

9 May 2018

issue

1

1 reference

9 May 2018

page(s)

182-185

1 reference

9 May 2018

Global genomic characterization of acute lymphoblastic leukemia

cites work

1 reference

https://api.crossref.org/works/10.1038/LEU.2013.282

Biology, risk stratification, and therapy of pediatric acute leukemias: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LEU.2013.282

Treatment of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LEU.2013.282

The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LEU.2013.282

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LEU.2013.282

Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LEU.2013.282

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leu

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LEU.2013.282

The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LEU.2013.282

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LEU.2013.282

Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LEU.2013.282

Promotion and maintenance of leukemia by ERG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LEU.2013.282

An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24072102

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24072102

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24072102

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/LEU.2013.282

1 reference

9 May 2018

1 reference

9 May 2018